T-box factors play critical roles in embryonic development and have been implicated in cell cycle regulation and cancer. For example, Tbx2 can suppress senescence through a mechanism involving the repression of the cyclin-dependent kinase inhibitors, p19
ARF and p21
WAF1/CIP1/SDII , and the Tbx2 gene is deregulated in melanoma, breast and pancreatic cancers. In this study, several transformed human lung fibroblast cell lines were shown to downregulate Tbx2. To further investigate the role of Tbx2 in oncogenesis we therefore stably reexpressed Tbx2 in one such cell line. Compared to their parental cells, the resulting Tbx2-expressing cells are larger, with binucleate and lobular nuclei containing double the number of chromosomes. Moreover, these cells had an increase in frequency of several features of genomic instability such as chromosome missegregation, chromosomal rearrangements and polyploidy. While grossly abnormal, these cells still divide and give rise to cells that are resistant to the chemotherapeutic drug cisplatin. Furthermore, this is shown to be neither species nor cell type dependent, as ectopically expressing Tbx2 in a murine melanoma cell line also induce mitotic defects and polyploidy. These results have important implications for our understanding of the role of Tbx2 in tumorigenesis because polyploidy frequently precedes aneuploidy, which is associated with high malignancy and poor prognosis.
Introduction
The T-box transcription factor family is characterized by a highly conserved DNA-binding domain, the T box, which binds specific promoter sequences in target genes. Members of this family play a crucial role in embryonic development and mutations affecting their function can result in human disorders with dramatic phenotypes (Naiche et al., 2005) . In addition, T-box factors have been implicated in cell cycle regulation and in the genesis of cancer. Both Tbx2 and Tbx3, for example, can prevent senescence in mouse embryonic fibroblasts and ST.Hdh Q111 striatal cells through a mechanism involving their ability to repress the cyclin-dependent kinase inhibitors p19
ARF (Jacobs et al., 2000; Carlson et al., 2001; Brummelkamp et al., 2002) and p21 WAF1/CIP1/SDII (referred to as p21) (Prince et al., 2004) . Ectopic expression of Tbx3 together with oncogenic Ras or Myc in embryonic mouse fibroblasts leads to cellular transformation and suppression of apoptosis (Carlson et al., 2002) . Furthermore, both Tbx2 and Tbx3 are expressed in the developing breast (Jerome-Majewska et al., 2005) and their genes are amplified and/or overexpressed in some breast tumors (Sinclair et al., 2002; Packham and Brook, 2003) and in certain breast cancer cell lines Fan et al., 2004) . Tbx2 is also overexpressed in 50% of pancreatic cancer cell lines (Mahlamaki et al., 2002) and in melanomas where it was shown to function as an anti-senescence factor (Vance et al., 2005) . These results suggest that T-box factors may contribute to oncogenesis through suppressing senescence but whether additional mechanisms are involved remains to be elucidated.
Genomic instability, a hallmark of transformed cells, often culminates in aneuploidy as a result of failure to execute proper cell division. Signaling checkpoints that elicit temporary delays in cell cycle progression serve as an important defense against genomic instability (Elledge, 1996; Paulovich et al., 1997) . These checkpoints, which involve a combination of cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors, can be activated during G 1 , G 2 or the mitotic spindle assembly checkpoints (Rieder and Maiato, 2004; Huang et al., 2005) . In particular failure to detect specific mitotic defects has been associated with polyploidy and cancer. These defects include the missegregation of defective chromosomes (for example, unrepaired DNA), misattached kinetochore or a defective mitotic spindle. Ordinarily, when these defects are detected, a cell may undergo mitotic catastrophe, a process involving the generation of binucleate, tetraploid cells which are eliminated and hence prevented from reentering the cell cycle in a p21-and p53-dependent manner (Bunz et al., 1998; Andreassen et al., 2001) . In transformed cells, however, these tetraploid cells are able to reenter the cell cycle through bypassing the relevant checkpoints. Genomic instability is thought to drive tumorigenesis and the resulting increase in DNA content promotes the ability to adapt to changing physiological conditions and the emergence of chemotherapeutic drug-resistant cells (Nigg, 2002) .
Although Tbx2 has been reported to be upregulated in a variety of cancers, this study shows that while Tbx2 is expressed in normal lung fibroblasts it is downregulated in several of its transformed counterparts. To investigate the implication of this downregulation of Tbx2 upon cellular transformation, Tbx2 was reexpressed in a transformed lung fibroblast cell line. These Tbx2-expressing cells experience an initial block in cytokinesis. With increasing passage, however, the cells acquire the ability to bypass this block, resulting in the formation of genetically unstable polyploid cells with increased resistance to the chemotherapeutic drug cisplatin.
Results
Reexpression of Tbx2 in CT-1 cells results in a decrease in cell proliferation rate and an altered morphology We have previously shown that Tbx2 mRNA and protein is expressed in normal WI-38 lung fibroblast cell lines, but not in the SV40-transformed WI-38 (SV40WI-38), the Co-60 gamma irradiated WI-38 (CT-1) and the human fibrosarcoma (HT1080) cell lines (Teng et al., 2007) .
To understand the significance of Tbx2 downregulation in the transformation of human lung fibroblasts, an expression construct in which the cytomegalovirus promoter drives expression of human Tbx2 was transfected into CT-1 cells. A number of G418-resistant clones were tested for Tbx2 expression. Figure 1a shows the presence of Tbx2 protein in two representative clones (CT-Tbx2(2) and CT-Tbx2(3)), which is absent in cells transfected with the empty vector (CT-E) and the parental CT-1 cells. Figure 1b shows that WI-38 cells have much higher levels of Tbx2 protein compared to the CT-Tbx2 clones and therefore any subsequent changes observed in the CT-Tbx2 cells were not due to abnormally high levels of Tbx2.
While expanding the CT-E and CT-Tbx2 cell lines, it was observed that the Tbx2-expressing cells grew much slower than the CT-E cells. To explore this further, the growth rate of these cell lines was compared using a hemocytometer to count cells over a 9-day culture period. In keeping with our observations, the CT-Tbx2 cells had a decreased cell proliferation rate (Figure 1c) , growing approximately 2.5 times more slowly than the CT-E cells on day 9. To confirm the effect seen for Tbx2 on cell proliferation we performed 5-bromo-2-deoxyuridine (BrdU) incorporation assays in which CT-E and the two CT-Tbx2 cell lines were pulsed with BrdU for 1 and 8 h. Figure 1d shows the total number of BrdU-positive cells expressed as a percentage of the total number of cells from 10 fields of view for each cell line. Whereas, similar numbers of CT-E cells had incorporated BrdU as the CT-Tbx2 cell lines at 1 h, after 8 h 97% of the CT-E cells had incorporated BrdU compared to 76 and 48% for the CT-Tbx2(2) and CTTbx2(3), respectively. These results thus confirm that Tbx2 does indeed have a negative effect on cell proliferation. Furthermore, we observed that the CTTbx2 cells had a morphology that was significantly different to that of the CT-E and untransfected cells. The CT-Tbx2 cells were larger and their cell borders less defined (Figure 1e ).
Ectopic Tbx2 expression induces a G 2 /M arrest Several of the CT-Tbx2 cells had large nuclei or were binucleate suggesting that they fail to undergo cytokinesis. This was confirmed by flow cytometry, which revealed that Tbx2-expressing cells had a cell cycle profile very different to normal cycling cells as seen for the CT-E cells (Figure 1f ). Whereas 73% of the CTTbx2 cells had a DNA content of 4n or greater, only 15% of the CT-E cells were 4n. These results suggested that the Tbx2-expressing cells were arrested at either a G 2 or M checkpoint. We therefore explored the possibility that Tbx2 may be exerting an effect on key cell cycle proteins involved in regulating these two checkpoints by comparing the levels of p53, p21, cyclin B1 and p14 ARF (human homolog of p19 ARF ) in CT-E and CT-Tbx2 cells. No detectable differences in the levels of the p53, p21 and cyclin B1 proteins were seen when they were standardized to tubulin levels in western blot analyses (Figure 1g ). Interestingly, p14 ARF levels were higher in the CT-Tbx2 cells, which could be as a result of the cells being blocked in G 2 . Furthermore, as shown in Figure 1f (see arrow), Tbx2 induced apoptosis in a small number of CT-Tbx2 cells as indicated by a sub-G 1 peak.
We next tested whether ectopically expressing Tbx2 in another cell type would result in similar defects seen in the CT-Tbx2 cells. For these experiments we chose the K1735 murine melanoma cell line that does not express endogenous Tbx2 and infected them with a pBabePuro retrovirus expressing SV5-tagged Tbx2. Following selection with puromycin individual clones were isolated and examined for Tbx2 expression by reverse transcription (RT)-PCR ( Figure 2a ). We were unable to detect Tbx2 protein levels using an anti-Tbx2 antibody, indicating that Tbx2 protein is expressed at low levels compared to cell lines that naturally express endogenous Tbx2. Although several clones were isolated all exhibited a similar phenotype and the results obtained for two, clones 4 and 10, are presented. As seen in the CTTbx2 cell lines, both of the K1735 cell lines expressing Tbx2 analysed proliferated at a slower rate than the parental cells ( Figure 2b ) and exhibited an altered morphology ( Figure 2c ). Furthermore, flow cytometry ( Figure 2d ) revealed that the K1735-Tbx2 cells display an abnormal cell cycle profile with a substantial increase in the G 2 fraction and in some instances the emergence of an 8n (G 2 /M tetraploid) peak was also seen (Figure 2d , right hand histogram), further indicating a defect in mitosis. These results confirmed that the effects of Tbx2 in CT-Tbx2 cells were not species or cell type dependent.
Ectopic Tbx2 expression induces mitotic defects and polyploidy With increasing passage of the CT-Tbx2 cell lines, fluorescence-activated cell sorting (FACS) analyses revealed the gradual appearance of an 8n (G 2 /M tetraploid) peak (Figure 3a) . These results are in agreement with previous reports that checkpoint activation is often only transient, with some cells 'slipping' past the arrest and producing a tetraploid population due to defective cell division (Storchova and Pellman, 2004) . We next investigated whether the CT-Tbx2 cells do indeed have double the number of chromosomes compared to that contained in CT-E cells. Metaphase spreads (Figure 3b ) confirmed that all CT-Tbx2 cells analysed had at least 160 chromosomes compared to a maximum of 85 chromosomes seen in CT-E cells. As expected, the normal WI-38 cells had 46 chromosomes. The observation that CT-Tbx2 cells have an increased number of chromosomes suggested that overexpression of Tbx2 may be enhancing chromosomal instability (CIN). Indeed, results from experiments in which Giemsa-banding analysis was performed on metaphase chromosomes reveal that compared to CT-E cells CTTbx2 cells have an increase in the frequency of several chromosomal abnormalities indicative of CIN ( Figure 3c ). For example whereas dicentric and giant marker chromosomes were never seen in CT-E control cells, 78% of the CT-Tbx2 metaphase spreads had
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CT-Tbx2 (2) CT-Tbx2 ( Ectopic expression of Tbx2 results in polyploidy E Davis et al between one and three dicentric chromosomes (arrows) and 44% displayed giant marker chromosomes (D). In addition, while metaphase spreads of both the CT-E control and CT-Tbx2 cells contained very small marker chromosomes they occurred with twice the frequency in the CT-Tbx2 cells (arrowheads). Furthermore, by comparison to the CT-E control cells, CT-Tbx2 cells had almost no apparently normal chromosomes. Numerous derivative and unidentifiable chromosomes (n), which must have resulted from translocations or chromosomal fusions, predominated. CT-Tbx2 cells also displayed nuclear abnormalities characteristic of CIN. For example, the presence of micronuclei was detected in 23% of cells analysed and many cells were binucleate or had large lobular nuclei (Figure 3d) , with the average size of CT-Tbx2 nuclei being 0.17 mm 2 compared to an average of 0.11 mm 2 obtained for the CT-E cells.
Polyploid cells with CIN can arise from a wide variety of cell cycle defects including chromosome missegregation, defective mitotic spindle function and defective cytokinesis (reviewed by Storchova and Pellman, 2004) . Therefore, to identify defects in CT-Tbx2 cells that could have triggered mitotic catastrophe and subsequent polyploidy, we examined anaphase and telophase chromosomes of CT-Tbx2 cells by immunofluorescence microscopy. Figure 3e shows examples of trailing/ lagging chromosomes and chromatin bridges in between separating anaphase chromosome masses (anaphase bridges), which was seen in, on average, 46% of cells undergoing mitosis. These mitotic defects may be the reason for the initial cell cycle block seen in CT-Tbx2 cells because anaphase bridges present a physical barrier to furrow formation that explain why the cells are unable to undergo successful cytokinesis. We also examined the effect of transiently expressing Tbx2 in Ectopic expression of Tbx2 results in polyploidy E Davis et al other cell lines with no endogenous Tbx2 and the resulting cells also exhibit lagging chromosomes and anaphase bridges as described in this study (our unpublished observations).
Effect of Tbx2 overexpression on cisplatin resistance
Reports have shown a relationship between genetic alterations, such as gene amplification and polyploidy, in tumors and the development of resistance to chemotherapeutic agents (Rothenberg and Ling, 1989; Baroja et al., 1998) . We therefore compared the effect of the anticancer drug, cisplatin, on the growth rate of the CT-Tbx2 and CT-E cells. The cells were cultured for 72 h, either in the presence or absence of cisplatin, and cell viability measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. As shown in Figure 4a , while 50 mM cisplatin killed all the CT-E cells, approximately 15% of CT-Tbx2 cells (as compared to untreated cells) continued to survive. Importantly, even at 166.7 mM of cisplatin approximately 8% of CT-Tbx2 cells were still viable (results not shown). Fifty percent growth inhibition (IC 50 ) in two CT-Tbx2 clones and CT-E cells (Figure 4b ) was noted at concentrations of 17, 16 and 12 mM cisplatin, respectively. To exclude the possibility that the apparent increased resistance of CT-Tbx2 to cisplatin was due to a percentage of the cells not dividing BrdU, incorporation assays were carried out. The cells were grown with or without 50 mM cisplatin for 48 h in the presence of BrdU and processed for BrdU incorporation by microscopy. Figure 4c shows that in the absence of the drug all of the CT-E and CT-Tbx2 cells have incorporated BrdU and have therefore divided at least once. Furthermore, in the presence of 50 mM cisplatin there are considerably more viable BrdU-positive CT-Tbx2 cells compared to the CT-E cells (Figure 4d ). These results confirmed that CT-Tbx2 cells that survive cisplatin treatment are indeed dividing. Taken together, the results show that Tbx2-expressing cells are more resistant to the anticancer drug cisplatin than the control cells.
Discussion
Several studies have implicated Tbx2 in tumorigenesis but whether it involves its anti-senescence function or additional mechanisms has not been elucidated. CIN is thought to be a key mechanism driving the genomic alterations associated with tumorigenesis. Defects in chromosome segregation during mitosis are one of the major causes of CIN in cells. This study demonstrates that reexpression of Tbx2 in a transformed lung fibroblast cell line results in cells that exhibit an increase in the frequency of several features of genetically unstable cells. These included chromosomal rearrangements resulting in derivative and unidentifiable chromosomes and small marker chromosomes. Importantly, giant marker and dicentric chromosomes were present in only the Tbx2-expressing cells. Interestingly, small marker chromosomes have been shown to be useful to cancer cells because they can harbor extra copies of genes that make a cell resistant to drugs used in chemotherapy (Danesi et al., 2003) . The increased number of these chromosomes in CT-Tbx2 cells may explain why, although grossly abnormal, these cells are still capable of dividing and give rise to cells that are resistant to the chemotherapeutic drug cisplatin. The results of this study suggest that one mechanism by which Tbx2 may contribute to tumorigenesis is through inducing genomic instability. Importantly, the CT-Tbx2 cells have much lower levels of the Tbx2 protein compared to the normal lung fibroblasts, WI-38. The changes in phenotype observed in the CT-Tbx2 cells are therefore not due to gross overexpression of Tbx2. Whether Tbx2 is able to induce the same genetic instability in normal cells has not been reported possibly because they have more robust cell cycle checkpoints which would lead to the elimination of tetraploid cells. This may be the reason why we (unpublished data), and others (Butz et al., 2004) , have found ectopic expression of Tbx2 in several cell lines to be toxic, compromising attempts at establishing Tbx2-expressing cell lines. Indeed, this is the first published report characterizing the properties of genetically engineered Tbx2-expressing cell lines. Understanding the mechanism by which Tbx2 induces increased genomic instability will be an important topic of future work. More specifically how Tbx2 causes the doubling of chromosomes, resulting in polyploidy, in already transformed lines may provide a clue to this mechanism. Polyploidy can be generated from a wide variety of errors in cell division (Nigg, 2002; Storchova and Pellman, 2004) . For example, anaphase chromosome segregation and cytokinesis are tightly coordinated Ectopic expression of Tbx2 results in polyploidy E Davis et al processes that have to be completed with high fidelity and are therefore regulated by complex surveillance mechanisms. When defects in either of these processes are detected a cell cycle arrest is imposed. In the event that these surveillance mechanisms are compromised cells can 'slip past' this arrest (Storchova and Pellman, 2004) resulting in polyploid cells. Initially, FACS analysis of CT-Tbx2 cells indicated that they were experiencing a cell cycle block in G 2 or M, which prevented cells from undergoing cytokinesis. The presence of lagging chromosomes and anaphase bridges in CT-Tbx2 cells supports the possibility that the block is in M phase and is due to a mitotic spindle checkpoint arrest. This suggests that the CT-1 cells do indeed have a functional mitotic spindle checkpoint. However, with increasing passage of CT-Tbx2 cells, a subpopulation of cells was able to proceed through the cell cycle undetected with a DNA content of 8n. It is therefore possible that altered Tbx2 protein levels affect chromosome segregation as well as negatively regulating normal surveillance mechanisms that would otherwise eliminate polyploid cells. We speculate that Tbx2 may be doing this, through regulating key cell cycle regulators especially since Tbx2 has been shown to interact directly with and repress the cell cycle regulators p19 ARF (Jacobs et al., 2000; Brummelkamp et al., 2002) and p21 (Prince et al., 2004) . We show that the changes observed in our Tbx2-expressing cells are not associated with alterations in p53, p21 or cyclin B protein levels but with increased levels of p14 ARF . Whether the increase in p14 ARF is due to a direct regulation of the gene by Tbx2, or a secondary effect induced by Tbx2 is not known.
Our results are consistent with, and provide functional support for, reports identifying a role for Tbx2 in the cell cycle. In a recent article by Bilican and Goding (2006) Tbx2 protein levels were shown to be tightly regulated during the various phases of the cell cycle with the levels peaking at G 2 and being greatly diminished in mitosis. These results suggest that Tbx2 may play an important role in G 2 . Interestingly, in CT-Tbx2 cells Tbx2 protein levels follow the same general pattern as described by Bilican and Goding (2006) , except that we find (data not shown) that Tbx2 protein levels remain high in M phase. It is therefore possible that when Tbx2 is either ectopically expressed or overexpressed as is the case in some cancers, the mechanism by which the protein is degraded after G 2 is compromised and hence the protein interferes with mitotic events, which may account for the lagging chromosomes and anaphase bridges seen in CT-Tbx2 cells. The results presented here therefore provide additional evidence for a role for Tbx2 in G 2 and may have important implications for our understanding of the exact role that Tbx2 plays in the cell cycle.
Materials and methods
Cell culture WI-38 human embryonic lung fibroblasts, their in vitro transformed counterparts WI-38 CT-1 (referred to as CT-1; Namba et al., 1980) , and the K1735 murine melanoma cell lines were maintained in Dulbecco's modified Eagles medium supplemented with 10% fetal calf serum (FCS), 100 U/ml penicillin and 100 mg/ml streptomycin. Cells were maintained at 371C in an atmosphere of 5% CO 2 .
Generation of stable cell lines expressing Tbx2
The CT-1 cells were derived by cobalt 60 g-irradiation of the normal WI-38 lung fibroblast cell line. To generate stably transfected cell lines, CT-1 cells were transfected with either the empty expression vector pcDNA3.1 ( þ ) or with this vector containing the full-length human Tbx2 cDNA using the standard calcium phosphate precipitation method (Teng et al., 2007) . Among subcloned cell lines, two cell lines were chosen for subsequent analysis: CT-Tbx2 contained the pcDNA3.1-Tbx2 construct while CT-E contained pcDNA3.1 empty vector. The K1735 murine melanoma cell line that does not express endogenous Tbx2 was infected with a pBabePuro retrovirus expressing SV5-tagged Tbx2. Individual clones were selected with 1 mg/ml puromycin to establish the K1735-Tbx2 cell lines.
RT-PCR
For the RT-PCR isolation of the Tbx2 cDNA total RNA was subjected to RT with avian myeloblastosis virus reverse transcriptase (Boehringer, UK) followed by first strand cDNA synthesis (Amersham First Strand cDNA synthesis kit) using appropriate primers.
Microscopy
Cells grown on glass coverslips were fixed in 4% paraformaldehyde at room temperature for 20 min and permeabilized in 0.2% Triton X-100 in phosphate-buffered saline (PBS) for 10 min. Cells were incubated in the dark with 1 mg/ml 4 0 6-diamidino-2-phenyl indole in PBS for 10 min and visualized by fluorescence microscopy.
Western blot analysis
Cells were harvested and solubilized at 41C in radioimmuno precipitation assay buffer (150 mM NaCl, 1% Triton X-100, 0.1% sodium dodecyl sulfate (SDS), 20 mM Tris (pH 7.5), 1% deoxycholate and a cocktail of protease inhibitors), centrifuged at 12 000 g for 20 min at 41C and the supernatants recovered. Protein concentrations were determined using the bicinchoninic acid assay (Pierce, Rockford, IL, USA), according to the manufacturer's instructions, with bovine serum albumin as the standard. Equal amounts of protein were loaded and separated on 10-15% SDS-polyacrylamide gels and transferred to Hybond C (Amersham, Amersham, UK). Membranes were blocked for 1 h at room temperature with PBS containing 5% nonfat dry milk, probed with appropriate primary antibodies followed by peroxidase-conjugated antimouse or anti-rabbit antibody (1:5000) and visualized by enhanced chemiluminescence (Pierce). The primary antibodies used were mouse monoclonal anti-Tbx2 62-2 (Prince et al., 2004) , mouse monoclonal anti-tubulin, rabbit polyclonal antip53, anti-p21 and anti-p19 (Santa Cruz Biotechnology, CA, USA) and mouse monoclonal anti-cyclin B1 (Transduction Laboratories, Franklin Lakes, NJ, USA).
Growth curves
Short-term growth of the CT-Tbx2 cell lines was compared to that of the CT-E control cell lines as described previously (Prince et al., 2003) . Cells were seeded in triplicate at 10 4 cells/ well in 12-well plates, collected by trypsinization and counted on a hemocytometer at 2-3 days intervals. As an alternative assay for proliferation, cells were plated at 4 Â 10 4 on sterile glass coverslips in 35 mm dishes and allowed to attach. The cells were then grown in medium containing 10 mM BrdU for 1 and 8 h followed by fixing with Carnoy's Fixative (1:3 acetic acid:methanol) at À201C for 20 min. For immunostaining, the cultures were incubated in 2 N hydrochloric acid at 371C for 1 h, neutralized in 0.1 M borate buffer (pH 8.5), rinsed with PBS containing 0.05% Tween-20 (PBS/T) and incubated in PBS/T with 5% swine serum for 30 min at 371C. BrdU was detected with the anti-BrdU mouse monoclonal antibody (6 mg/ml, Roche, Indianapolis, IN, USA) for 30 min at 371C, followed by a secondary immunoglobulin G coupled to Alexa 488 (1:1000, Molecular Probes, Eugene, OA, USA) for 30 min at 371C. Cells were rinsed with PBS/T, incubated in propidium iodide (PI, 20 mg/ml) for 20 min, mounted onto slides and visualized by fluorescence microscopy.
Flow cytometry
Cells were collected by trypsinization, washed twice with PBS, suspended in 2 ml of cold PBS and fixed in 8 ml of 70% cold ethanol for at least 30 min at À201C. Cells were pelleted by centrifugation, washed twice with PBS and treated for 15 min at 371C with 50 mg/ml RNase A. Cells were stained at room temperature with PI solution (2 mM MgCl 2 , 10mM Pipes buffer, 0.1 M NaCl, 0.1% Triton X-100, 0.01 mg/ml PI) and subjected to analysis in a Beckman Coulter Cytomics FC500 flow cytometer.
Metaphase spreads
Cells grown to 70% confluency on glass coverslips were arrested in metaphase by treatment with 0.1 mg/ml of colcemid for 1 h at 371C. Following hypotonic treatment in 0.56% KCl solution at 371C for 1 h, the cells were fixed in 1:3 acetic acid:methanol fixative at 371C for 1 h. Evaluation of the chromosome sets was carried out after conventional Giemsa staining. Metaphase chromosome spreads were prepared on acid-cleaned microscope slides using the standard method (Priest, 1977) . For G-banding staining, slides were incubated 3 s to 1 min in a trypsin (DIFCO, Maryland, MD, USA, 1:250) solution (0.1 g trypsin in 100 ml isotonic buffer). Slides were rinsed for a few seconds in a jar with FCS (2-3 ml FCS in 50 ml isotonic buffer) and then rinsed in isotonic buffer and incubated for 1.5-5 min in a Coplin jar with Giemsa stain (EM Science, Gibbstown, NJ, USA).
Resistance to cisplatin
Cisplatin, an alkylating chemotherapeutic drug, was kindly provided by Pharmachemie (Pty) Ltd (Haarlem, Holland). Cells were seeded in quadruplicate in a 96-well plate (3000 cells/well) and incubated for 72 h with cisplatin at concentrations ranging from 0 to 166.7 mM in culture medium. Cell viability was determined using the MTT assay according to the manufacturer's instructions (Roche). As an assay for cell viability, cells were plated at 3 Â 10 4 on sterile glass coverslips in 35 mm dishes and allowed to attach. The cells were then grown in medium containing cisplatin at concentrations ranging from 0 to 50 mM in the presence of 10 mM BrdU for 48 h, followed by fixing with Carnoy's Fixative (1:3 acetic acid/ methanol) at À201C for 20 min. Immunostaining for BrdU was as described above for growth curves.
